International Stem Cell Corp

International Stem Cell Corp. Stock Analysis ISCO

United States Health Care Nano Cap
International Stem Cell Corp. operates as a research and development company for the therapeutic market. The company is headquartered in San Diego, California and currently employs 32 full-time employees. The company went IPO on 2006-09-25. The firm is primarily a research and development company for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The firm's products are based on human cell culture and types of pluripotent stem cells and hpSCs. The firm's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.
Read More

International Stem Cell Corp (ISCO) Chart

Key Statistics of International Stem Cell Corp (ISCO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.17$0.17

Today's Open

$0.17

Volume

302.00

P/E Ratio (TTM)

-

52 Week Range

$0.11$0.27

Market Cap

1.12M

Avg. Volume

8894.08

Dividend Yield

-

Financial Metrics & Statements of International Stem Cell Corp (ISCO)

FAQ's for International Stem Cell Corp (ISCO)

  • According to Musaffa’s Shariah screening methodology, International Stem Cell Corp (ISCO) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.